Jean-Claude Lacherade1, Patricia Jabre2,3, Sylvie Bastuji-Garin2, David Grimaldi4, Pascal Fangio4, Valerie Théron4, Hervé Outin4, Bernard De Jonghe4. 1. Service de Réanimation Médico-chirurgicale, Centre Hospitalier de Poissy-St-Germain, 10 rue du Champ Gaillard, 78300, Poissy, France. jclacherade@chi-poissy-st-germain.fr. 2. Hôpital Henri-Mondor AP-HP, 51 avenue du Maréchal de Tassigny, 94000, Créteil, France. 3. Faculté de Médecine de Bobigny, EA 3409, Université Paris XIII, 74 rue Marcel Cachin, 93000, Bobigny, France. 4. Service de Réanimation Médico-chirurgicale, Centre Hospitalier de Poissy-St-Germain, 10 rue du Champ Gaillard, 78300, Poissy, France.
Abstract
OBJECTIVE: Intensive insulin therapy reduces mortality in subgroups of intensive care unit (ICU) patients, and awareness of the importance of blood glucose level (BGL) control has increased among ICU physicians and nurses. The impact of insulin treatment strategies on mortality may be influenced by their efficacy in achieving the target BGL range. We assessed the efficacy of an insulin treatment strategy in maintaining BGL within the target range, and we compared ICU mortality in patients who did and did not reach the BGL target. DESIGN: Prospective cohort study. SETTING: 12-bed medical ICU in a tertiary teaching hospital. PATIENTS AND PARTICIPANTS: Adults consecutively admitted over a 9-month period to an ICU where standard care included an insulin treatment strategy aimed at maintaining BGL<or=7 mmol/l. MEASUREMENTS AND MAIN RESULTS: 105 patients were included. Median SAPS II was 45 (31-54). Failure to control BGL (mean capillary BGL >7 mmol/l after initial hyperglycemia correction) occurred in 32 patients (31.1%) and was associated with a significant increase in ICU mortality (56.2 vs. 23.3% in patients with successful BGL control). In the multivariate analysis, failure to control BGL independently predicted death in the ICU (OR 5.9, 2.1-16.6, p<0.001). CONCLUSIONS: Failure to control BGL despite intensive insulin therapy was common and independently associated with ICU mortality. Failure to control BGL may considerably affect the overall impact of insulin treatment strategies on mortality.
OBJECTIVE: Intensive insulin therapy reduces mortality in subgroups of intensive care unit (ICU) patients, and awareness of the importance of blood glucose level (BGL) control has increased among ICU physicians and nurses. The impact of insulin treatment strategies on mortality may be influenced by their efficacy in achieving the target BGL range. We assessed the efficacy of an insulin treatment strategy in maintaining BGL within the target range, and we compared ICU mortality in patients who did and did not reach the BGL target. DESIGN: Prospective cohort study. SETTING: 12-bed medical ICU in a tertiary teaching hospital. PATIENTS AND PARTICIPANTS: Adults consecutively admitted over a 9-month period to an ICU where standard care included an insulin treatment strategy aimed at maintaining BGL<or=7 mmol/l. MEASUREMENTS AND MAIN RESULTS: 105 patients were included. Median SAPS II was 45 (31-54). Failure to control BGL (mean capillary BGL >7 mmol/l after initial hyperglycemia correction) occurred in 32 patients (31.1%) and was associated with a significant increase in ICU mortality (56.2 vs. 23.3% in patients with successful BGL control). In the multivariate analysis, failure to control BGL independently predicted death in the ICU (OR 5.9, 2.1-16.6, p<0.001). CONCLUSIONS: Failure to control BGL despite intensive insulin therapy was common and independently associated with ICU mortality. Failure to control BGL may considerably affect the overall impact of insulin treatment strategies on mortality.
Authors: Joseph McMullin; Jan Brozek; Roman Jaeschke; Cindy Hamielec; Vinay Dhingra; Graeme Rocker; Andreas Freitag; James Gibson; Deborah Cook Journal: Intensive Care Med Date: 2004-03-30 Impact factor: 17.440
Authors: Salmaan Kanji; Avinder Singh; Michael Tierney; Hilary Meggison; Lauralyn McIntyre; Paul C Hebert Journal: Intensive Care Med Date: 2004-03-20 Impact factor: 17.440
Authors: Philip A Goldberg; Mark D Siegel; Robert S Sherwin; Joshua I Halickman; Michelle Lee; Valerie A Bailey; Sandy L Lee; James D Dziura; Silvio E Inzucchi Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Ulrike Holzinger; Joanna Warszawska; Reinhard Kitzberger; Harald Herkner; Philipp G H Metnitz; Christian Madl Journal: Intensive Care Med Date: 2009-04-07 Impact factor: 17.440
Authors: Saeid Eslami; Ameen Abu-Hanna; Nicolette F de Keizer; Rob J Bosman; Peter E Spronk; Evert de Jonge; Marcus J Schultz Journal: Intensive Care Med Date: 2010-06-09 Impact factor: 17.440
Authors: Christoph Pachler; Johannes Plank; Heinz Weinhandl; Ludovic J Chassin; Malgorzata E Wilinska; Roman Kulnik; Peter Kaufmann; Karl-Heinz Smolle; Ernst Pilger; Thomas R Pieber; Martin Ellmerer; Roman Hovorka Journal: Intensive Care Med Date: 2008-02-23 Impact factor: 17.440
Authors: Jason L Sperry; Heidi L Frankel; Avery B Nathens; Grant E O'keefe; Joseph Cuschieri; Ernest E Moore; Ronald V Maier; Joseph P Minei Journal: J Trauma Date: 2009-04